Dongping (Don) Lin, Ph.D.

President of US Innovation Center and Jiaxing Nuojiang Institute of Biotech

Founding Partner of Guoqian VC

Wenhua (Jocelyn) Yu, Ph.D.

Intellectual Property Attorney

Jones Day

Topic

Intellectual Property and Start Up

Business considerations, practice, and experience of intellectual property for the executives and startups in life sciences Industry.

Free Registration

Registration is free but required (max 70 registrants). Parking is free. Light food/snacks are provided. 

Speakers

Dr. Lin has more than 30 years of experience in managing medical device companies and in bringing innovative concepts to successful products. He held positions in corporation management, product development, intellectual property, and regulatory affairs; His expertise is in algorithm, software, cardiovascular and respiratory devices, and wireless and remote monitoring devices.

Before co-founding US Innovation Center and Jiaxing Nuojiang Institute of Biotech, Dr. Lin co-founded Guoqian VC, and serviced as Chief Scientist, Deputy General Manager, Vice President, and Chief Engineer of Mindray Bio-Medical Electronics, Co., Ltd., the largest medical company in China; and Chief Intellectual Property Officer, Chief Software Architecture, and Chief Technical Officer of Cardiac Science, Inc., which he helped to build from his garage to NASDAQ national market. He helped many startups to become public companies and/or be acquired. He led the development of many innovative and award winning medical devices. He has over 20 articles/presentations in the biomedical field; and obtained over ten patents. He made contribution to many national and international standards.

Dr. Lin received his Ph.D. and Master degrees from the University of Michigan and Bachelor degree from Beijing Normal University.

Dr. Jocelyn Yu’s practice focuses on counseling clients on strategies for maximizing intellectual property (IP) protection and leveraging IP rights in business strategies and transactions. She services a wide spectrum of clients in the life science industry, ranging from biotech start-ups to the world’s largest pharmaceutical companies.

Jocelyn has extensive experience in preparing and prosecuting patent applications in various countries and jurisdictions in the world, as well as constructing and managing global patent portfolios. Her main technology areas include genetic engineering, microbiology, immunotherapies (e.g., antibodies, CAR-T, CpG), diagnostics and precision medicine, gene editing technology (e.g., CRISPR), and natural peptide platform technology. She also frequently conducts due diligence investigations to assist with client’s IP and business strategies, including patent evaluations, IP landscape searches, patentability opinions, validity opinions, and freedom-to-operate opinions.

On the transactional side of her practice, Jocelyn counsels clients on legal and business issues relating to technology, IP, and commercial transactions. She also assists biotech and pharmaceutical companies constructing their technology transactions and collaborations (e.g.,

joint research and development collaborations, funded researches, and IP licensing transactions), including U.S. – China cross border transactions. She assists with the negotiation, review and preparation of various types of commercial agreements involving IP rights, and conducts due diligence in support of the transaction.

Before practicing law, Jocelyn earned her Ph.D. at Pennsylvania State University, while she worked in the areas of genetic and molecular mechanisms of synaptic neurotransmission and coauthored several peer-reviewed scientific publications. She obtained her B.S. in pharmacology from Wuhan University (China). Jocelyn currently serves on the Capital Development Committee of BioCom, a California life science coalition.